Q3 2024 |
5 |
$153M |
+$9.01M |
$0 |
+$9.01M |
PHVS, KURA, SNDX, LYEL, RLAY
|
13F-HR |
11/14/2024, 02:18 PM |
Q2 2024 |
4 |
$149M |
+$4.79M |
-$25.7M |
-$20.9M |
PHVS, KURA, SNDX, LYEL
|
13F-HR |
8/13/2024, 02:27 PM |
Q1 2024 |
5 |
$198M |
$0 |
$0 |
|
PHVS, KURA, KNTE, SNDX, LYEL
|
13F-HR |
5/15/2024, 12:28 PM |
Q4 2023 |
5 |
$198M |
+$8.29M |
-$46.8M |
-$38.5M |
PHVS, KURA, KNTE, SNDX, LYEL
|
13F-HR |
2/13/2024, 02:04 PM |
Q3 2023 |
7 |
$180M |
$0 |
-$1.35M |
-$1.35M |
PHVS, CBAY, ACRS, KURA, KNTE
|
13F-HR |
11/13/2023, 04:43 PM |
Q2 2023 |
7 |
$203M |
+$7.52M |
-$4.07M |
+$3.45M |
PHVS, LYEL, KNTE, ACRS, KURA
|
13F-HR |
8/11/2023, 06:52 AM |
Q1 2023 |
8 |
$193M |
$0 |
$0 |
|
KNTE, PHVS, LYEL, ACRS, KURA
|
13F-HR |
5/12/2023, 09:17 AM |
Q4 2022 |
8 |
$234M |
+$4.71M |
$0 |
+$4.71M |
KNTE, ACRS, PHVS, LYEL, KURA
|
13F-HR |
2/13/2023, 04:49 PM |
Q3 2022 |
8 |
$311M |
+$16.6M |
-$32.6M |
-$16.1M |
KNTE, LYEL, ACRS, KURA, PHVS
|
13F-HR |
11/14/2022, 09:28 AM |
Q2 2022 |
8 |
$371M |
$0 |
-$14M |
-$14M |
KNTE, LYEL, PHVS, ACRS, KURA
|
13F-HR |
8/12/2022, 09:25 AM |
Q1 2022 |
9 |
$357M |
$0 |
-$15.9M |
-$15.9M |
KNTE, LYEL, PHVS, ACRS, KURA
|
13F-HR |
5/13/2022, 09:07 AM |
Q4 2021 |
9 |
$486M |
$0 |
-$14.5M |
-$14.5M |
KNTE, LYEL, ACRS, PHVS, QSI
|
13F-HR |
2/11/2022, 03:01 PM |
Q3 2021 |
12 |
$679M |
+$11.9M |
-$31.1M |
-$19.3M |
KNTE, LYEL, ACRS, PHVS, QSI
|
13F-HR |
11/12/2021, 09:56 AM |
Q2 2021 |
13 |
$740M |
+$273M |
-$214M |
+$58.9M |
KNTE, LYEL, PHVS, ACRS, QSI
|
13F-HR |
8/13/2021, 06:21 PM |
Q1 2021 |
13 |
$835M |
+$158M |
-$114M |
+$43.7M |
KNTE, PHVS, ACRS, KROS, RLAY
|
13F-HR |
5/14/2021, 07:19 PM |
Q4 2020 |
13 |
$921M |
+$446M |
-$39.9M |
+$406M |
KNTE, KROS, RLAY, ALXO, NRIX
|
13F-HR |
2/16/2021, 08:48 AM |
Q3 2020 |
15 |
$443M |
+$229M |
-$42.1M |
+$187M |
RLAY, NRIX, KROS, KURA, ALXO
|
13F-HR |
11/13/2020, 10:55 AM |
Q2 2020 |
12 |
$205M |
+$129M |
-$54.4M |
+$74.5M |
KROS, CYTK, KURA, FULC, PCVX
|
13F-HR |
8/13/2020, 10:04 AM |
Q1 2020 |
11 |
$81.1M |
+$12M |
-$120M |
-$108M |
CYTK, MYOK, FULC, INSM, BHVN
|
Restatement |
5/28/2020, 12:58 PM |
Q4 2019 |
14 |
$232M |
+$23.3M |
-$160M |
-$136M |
AERI, MDCO, INSM, CYTK, FULC
|
13F-HR |
2/14/2020, 03:31 PM |
Q3 2019 |
17 |
$306M |
+$49.7M |
-$49.3M |
+$421K |
TPTX, AERI, INSM, MDCO, ASND
|
13F-HR |
11/13/2019, 09:05 AM |
Q2 2019 |
20 |
$348M |
+$122M |
-$21.9M |
+$100M |
TPTX, INSM, ASND, ALEC, CYTK
|
13F-HR |
8/13/2019, 10:02 AM |
Q1 2019 |
16 |
$268M |
+$23.5M |
-$68.4M |
-$44.9M |
INSM, CBAY, ASND, BHVN, OPTN
|
13F-HR |
5/14/2019, 10:47 AM |
Q4 2018 |
18 |
$218M |
+$40.7M |
-$54.9M |
-$14.2M |
BHVN, INSM, MYOK, CBAY, IMMU
|
13F-HR |
2/13/2019, 05:12 PM |
Q3 2018 |
21 |
$305M |
+$47.2M |
-$10.5M |
+$36.8M |
INSM, MYOK, BHVN, IMMU, ABUS
|
13F-HR |
11/13/2018, 02:33 PM |
Q2 2018 |
16 |
$288M |
+$65.3M |
-$43.4M |
+$21.9M |
INSM, BHVN, IMMU, MYOK, CBAY
|
13F-HR |
8/14/2018, 04:03 PM |
Q1 2018 |
15 |
$222M |
+$73.2M |
-$8.63M |
+$64.6M |
INSM, ASND, CBAY, BHVN, MYOK
|
13F-HR |
5/15/2018, 09:43 AM |
Q4 2017 |
13 |
$143M |
$0 |
$0 |
|
INSM, ASND, CBAY, IMMU, MYOK
|
13F-HR |
2/13/2018, 01:14 PM |